References
Bartalena L. Recent achievements in studies on thyroid hormone-binding proteins. Endocr. Rev. 11: 47, 1990.
Gordon A.H., Gross J., O’Connor D., Pitt-Rivers R. Nature of the circulating thyroid hormone-plasma protein complex. Nature 169: 19, 1952.
Larson F., Deiss W.P., Albright E.C. Localization of protein-bound iodine by filter paper electrophoresis. Science 115: 626, 1952.
Robbins J., Rall J.E. Zone electrophoresis on filter paper of serum 1–131 after radioiodine administration. Proc. Soc. Exp. Biol. Med. 81: 530, 1952.
Gershengorn M.C., Cheng S.-Y., Lippoldt R.E., Lord R.S., Robbins J. Characterization of human thyroxine-binding globulin. Evidence for a single polypeptide chain. J. Biol. Chem. 252: 8713, 1977.
Bartalena L., Robbins J. Variations in thyroid hormone transport proteins and their clinical implications. Thyroid 2: 237, 1992.
Refetoff S. Inherited thyroxine-binding globulin abnormalities in man. Endocr. Rev. 10: 275, 1989.
Janssen O.E., Bertenshaw R., Takeda K., Weiss R., Refetoff S. Molecular basis of inherited thyroxine-binding globulin defects. Trends Endocrinol. Metab. 3: 49, 1992.
Robbins J., Bartalena L. Plasma transport of thyroid hormones. In: Hennemann G. (ed.), Thyroid Hormone Metabolism. Marcel Dekker Inc., New York, 1986, p. 3.
Bartalena L., Tata J.R., Robbins J. Characterization of nascent and secreted thyroxine-binding globulin in human hepatoma (Hep G2) cells. J. Biol. Chem. 259: 13605, 1984.
Trent J.M., Flink I.L., Morkin E., Van Tuinen P., Ledbetter D.H. Localization of the human thyroxine-binding globulin gene to the long arm of the X chromosome (Xq 21–22). Am. J. Hum. Genet. 41: 428, 1987.
Kambe F., Seo H., Murata Y., Matsui N. Cloning of a complementary deoxyribonucleic acid coding for human thyroxine-binding globulin (TBG): existence of two TBG messenger RNA species possessing different 3′-untranslated regions. Mol. Endocrinol. 2: 181, 1988.
Flink I.L., Bailey T.J., Gustafson TA, Markham B.E., Morkin E. Complete amino acid sequence of human thyroxine-binding globulin deduced from cloned DNA: close homology to the serine antiproteases. Proc. Natl. Acad. Sci. USA 83: 7708, 1986.
Imamura S., Mori Y., Murata Y., Yamamori I., Miura Y., Oiso Y., Seo H., Matsui N., Refetoff S. Molecular cloning and primary structure of rat thyroxine-binding globulin. Biochemistry 30: 5406, 1991.
Hammond G.L., Smith C.L., Goping I.S., Underhill D.A., Harley M.J., Reventos J., Musto N.A., Gunsalus G.L., Bardin C.W. Primary structure of human corticosteroid binding globulin, deduced from hepatic and pulmonary cDNAs, exhibits homology with serine protease inhibitors. Proc. Natl. Acad. Sci. USA 84: 5153, 1987.
Pemberton P.A., Stein P.E., Pepys M.B., Potter J.M., Carrell R.W. Hormone binding globulins undergo serpin conformational change in inflammation. Nature 336: 257, 1988.
Gershengorn M.C., Lippoldt R.E., Edelhoch H., Robbins J. Structure and stability of human thyroxine-binding globulin. J. Biol. Chem. 252: 8719, 1977.
Johnson M.L., Lippoldt R.E., Gershengorn M.C., Robbins J., Edelhoch H. Molecular transitions of human thyroxine-binding globulin. Arch. Biochem. Biophys. 200: 288, 1980.
Robbins J. Thyroid hormone transport proteins and the physiology of hormone binding. In: Braverman L.E., Utiger R.D. (eds.), Werner’s and Ingbar’s The Thyroid. A Fundamental and Clinical Text, Ed. 6. J.B. Lippincott Company, Philadelphia, 1991, p. 111.
Marshall J.S., Pensky J., Williams S. Studies on human thyroxine-binding globulin. VIII. Isoelectric focusing evidence for microheterogeneity of thyroxine-binding globulin. Arch. Biochem. Biophys. 156: 456, 1973.
Jarvis J.A., Munro S.L.A., Craik D.J. Homology model of thyroxine binding globulin and elucidation of the thyroid hormone binding site. Protein Engng. 5: 61, 1992.
Terry C.J., Blake C.C.F. Comparison of the modelled thyroxine binding site in TBG with the experimentally determined site in transthyretin. Protein Engng. 5: 505, 1992.
Blake C.C.F., Geisow M.J., Swan I.D.A. Structure of human plasma prealbumin at 2.5 A resolution. A preliminary report on the polypeptide chain conformation, quaternary structure and thyroxine binding. J. Mol. Biol. 88: 1, 1974.
Blake C.C.F., Oatley S.J. Protein-DNA and protein-hormone interactions in prealbumin: a model of the thyroid hormone nuclear receptor? Nature 268: 115, 1977.
Blake C.C.F., Geisow M.J., Oatley S.J., Rerat B., Rerat C. Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A. J. Mol. Biol. 121: 339, 1978.
Grimaldi S., Edelhoch H., Robbins J. Effects of thyroxine binding on the stability, conformation, and fluorescence properties of thyroxine-binding globulin. Biochemistry 21: 145, 1982.
Grimaldi S., Robbins J. Effect of thyroxine on molecular properties of native and dansylated thyroxine-binding globulin. Endocrinol. Exp. (Bratisl.) 16: 273, 1982.
Zinn A.B., Marshall J.S., Carlson D.M. Preparation of glycopeptides and oligosaccharides from thyroxine-binding globulin. J. Biol. Chem. 253: 6761, 1978.
Zinn A.B., Marshall J.S., Carlson D.M. Carbohydrate structures of thyroxine-binding globulin and their effects on hepatocyte membrane binding. J. Biol. Chem. 253: 6768, 1978.
Grimaldi S., Robbins J., Edelhoch H. Interaction of carbohydrate and protein in thyroxine binding globulin. Biochemistry 24: 3771, 1985.
Refetoff S., Fang V.S., Marshall J.S. Studies on human thyroxine-binding globulin (TBG). IX. Some physical, chemical and biological properties of radioiodinated TBG and partially desialylated TBG (STBG). J.Clin. Invest. 56: 177, 1975.
Marshall J.S., Green A.M., Pensky J., Williams S., Zinn A., Carlson D.M. Measurement of circulating desialylated glycoproteins and correlation with hepatocellular damage. J.Clin. Invest. 54: 555, 1974.
Ain K.B., Mori Y., Refetoff S. Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentration. J. Clin. Endocrinol. Metab. 65: 689, 1987.
Lasne Y., Lasne F., Benzerara O. Microheterogeneity and polymorphism of human serum thyroxine-binding globulin. Study by isoelectric focusing and radioprint immunofixation. Biochim. Biophys. Acta 624: 333, 1980.
Gartner R., Henke R., Horn R., Pickardt C.R., Scriba P.C. Thyroxine-binding globulin: investigation of microheterogeneity. J. Clin. Endocrinol. Metab. 52: 657, 1981.
Lasne F., Benzerara O., Lasne Y. Role of sialic acid in the microheterogeneity of serum thyroxine-binding globulin. Study by two-dimensional isoelectric focusing. Biochim. Biophys. Acta 703: 49, 1982.
Grimaldi S., Bartalena L., Ramacciotti C., Robbins J. Polymorphism of human thyroxine-binding globulin. J. Clin. Endocrinol. Metab. 57: 1186, 1983.
Vranckx R., Savu L., Maya M., Nunez E.A. Characterization of a major development-regulated serum thyroxine-binding globulin in the euthyroid mouse. Biochem. J. 271: 373, 1990.
Rouaze-Romet M., Vranckx R., Savu L., Nunez E.A. Structural and functional microheterogeneity of rat thyroxine-binding globulin during ontogenesis. Biochem. J. 286: 125, 1992.
Cheng S.-Y., Morrone S., Robbins J. Effect of deglycosylation on the binding and immunoreactivity of human thyroxine-binding globulin. J. Biol. Chem. 254: 8830, 1979.
Bartalena L., Robbins J. Effect of tunicamycin and monensin on secretion of thyroxine-binding globulin by cultured human hepatoma (Hep G2) cells. J. Biol. Chem. 259: 13610, 1984.
Murata Y,, Magner J.A., Refetoff S. The role of glycosylation in the molecular conformation and secretion of thyroxine-binding globulin. Endocrinology 118: 1614, 1986.
Bartalena L., Robbins J., Pacchiarotti E., Martino E., Pinchera A. Further studies on the role of glycosylation in thyroxine-binding globulin secretion by human hepatoma (Hep G2) cells. Endocrinology 121: 1497, 1987.
Kobayashi M., Horiuchi R., Hachisu T., Takikawa H. Dualistic effect of thyroid hormone on a human hepatoma cell line: inhibition of thyroxine-binding globulin synthesis and stimulation of α1-acid glycoprotein synthesis. Endocrinology 123: 631, 1988.
Savu L., Vranckx R., Maya M., Nunez E.A. A thyroxine-binding globulin (TBG)-like protein in the sera of developing and adult rats. Biochem. Biophys. Res. Commun. 148: 1165, 1987.
Savu L., Vranckx R., Maya M., Gripois D., Blouquit M.-F., Nunez E.A. Thyroxine-binding globulin and thyroxine-binding prealbumin in hypothyroid and hyperthyroid developing rats. Biochim. Biophys. Acta 992: 379, 1989.
Young R.A., Meyers B., Alex S., Fang S., Braverman LE. Thyroxine binding to serum thyroxine-binding globulin in thyroidectomized adult and normal neonatal rats. Endocrinology 122: 2318, 1988.
Savu L., Vranckx R., Rouaze-Romet M., Maya M., Nunez E.A., Tréton J., Flink I.L. A senescence up-regulated protein: the rat thyroxine-binding globulin (TBG). Biochim. Biophys Acta 1097: 19, 1991.
Vranckx R., Rouaze M., Savu L., Nunez E.A., Beaumont C., Flink I.L. The hepatic biosynthesis of rat thyroxine binding globulin (TBG): demonstration, ontogenesis and up-regulation in experimental hypothyroidism. Biochem. Biophys. Res. Commun. 167: 317, 1990.
Glinoer D., Gershengorn M.C., Dubois A., Robbins J. Stimulation of thyroxine-binding globulin synthesis by isolated Rhesus monkey hepatocytes after in vivo β-estradiol administration. Endocrinology 100: 807, 1977.
Ain K.B., Refetoff S. Relationship of oligosaccharide modification to the cause of thyroxine-binding globulin (TBG) excess. J. Clin. Endocrinol. Metab. 66: 1037, 1988.
Ain K.B., Refetoff S., Same D.H., Murata Y. Effect of estrogen on the synthesis and secretion of thyroxine-binding globulin (TBG) by a human hepatoma cell line, Hep G2. Mol. Endocrinol. 2: 313, 1988.
Bartalena L., Bogazzi F., Donadel G., Martino E., Gabrielli F., Pinchera A. The differentiation-inducing agent sodium butyrate produces divergent effects on albumin and thyroxine-binding globulin synthesis by human hepatoblastoma-derived (Hep G2) cells. J. Endocrinol. Invest. 13: 917, 1990.
Whitecar J.P., Bodey G.P., Harris J.E., Freireich E.J. Current concepts of L-asparaginase. N. Engl. J. Med. 282: 732, 1970.
Garnick M.B., Larsen P.R. Acute deficiency of thyroxine-binding globulin during L-asparaginase therapy. N. Engl. J. Med. 301: 252, 1979.
Heidemann P.H., Strubbe P., Beck W. Transient secondary hypothyroidism and thyroxine binding globulin deficiency in leukemic children during polychemotherapy: an effect of L-asparaginase Eur. J. Pediatr. 136: 291, 1981.
Bartalena L., Martino E., Antonelli A., Pacchiarotti A., Robbins J., Pinchera A. Effect of the antileukemic agent L-asparaginase on thyroxine-binding globulin and albumin synthesis in cultured human hepatoma (Hep G2) cells. Endocrinology 119: 1185, 1986.
Heinrich P.C., Castell J.V., Andus T. Interleukin-6 and the acute phase response. Biochem. J. 265: 621, 1990.
Bartalena L., Farsetti A., Flink I.L., Robbins J. Effects of interleukin-6 on the expression of thyroid hormone-binding protein genes in cultured human hepatoblastoma-derived (Hep G2) cells. Mol. Endocrinol. 6: 935, 1992.
Beierwaltes W.H., Robbins J. Familial increase in thyroxine-binding sites in serum alpha globulin. J.Clin. Invest. 38: 1683, 1959.
Brown S.K., Bellisario R. Measurement of thyroxine binding globulin (TBG) levels from dried blood spot specimens: detection of TBG deficiency and TBG excess in infants. In: Genetic Disease: Screening and Management. Alan Liss Inc., New York, 1986, p. 373.
Griffiths K.D., Virdi N.K., Rayner P.H.W., Green A. Neonatal screening for congenital hypothyroidism by measurement of plasma thyroxine and thyroid stimulating hormone concentrations. Br. Med. J. 291 117, 1985.
Lyon I.C.T. Screening for hypothyroidism: the New Zealand experience. In: Naruse H., Irie M. (Eds.), Neonatal Screening. Excerpta Medica, Amsterdam, 1983, p. 111.
Refetoff S., Robin N.I., Alper C.A. Study of four new kindreds with inherited thyroxine-binding globulin abnormalities: possible mutations of a single gene locus. J.Clin. Invest. 51: 848, 1972.
Burr W.A., Ramsden D.B., Hoffenberg R. Hereditary abnormalities of thyroxine-binding globulin concentration. J. Med. 49: 295, 1980.
Sigurdsson G.A., Arnason G., Gudmundsson T.V., Kjeld M., Franzson L., Sigurdsson G. Familial elevation of serum thyroxine-binding globulin in an Icelandic family. Acta Endocrinol. (Copenh.) 107: 352, 1984.
Refetoff S., Murata Y., Vassart G., Chandramouli V., Marshall J.S. Radioimmunoassays specific for the tertiary and primary structures of thyroxine-binding globulin (TBG): measurement of denatured TBG in serum. J. Clin. Endocrinol. Metab. 59: 269, 1984.
Jones J.E., Seal U.S. X-chromosome linked inheritance of elevated thyroxine-binding globulin. J. Clin. Endocrinol. Metab. 27: 1521, 1967.
Mori Y., Refetoff S., Flink I.L., Charbonneau M., Murata Y., Seo H., Morkin E., Dussault J.H. Detection of the thyroxine-binding globulin (TBG) gene in six unrelated families with complete TBG deficiency. J. Clin. Endocrinol. Metab. 67: 727, 1988.
Yamamori I., Mori Y., Seo H., Hirooka Y., Imamura S., Miura Y., Matsui N., Oiso Y. Nucleotide deletion resulting in frameshift as a possible cause of complete thyroxine-binding globulin deficiency in six Japanese families. J. Clin. Endocrinol. Metab. 73: 262, 1991.
Li P., Janssen O.E., Takeda K., Bertenshaw R.H., Refetoff S. Complete thyroxine-binding globulin (TBG) deficiency caused by a single nucleotide deletion in the TBG gene. Metabolism 40: 1231, 1991.
Mori Y., Takeda K., Charbonneau M., Refetoff S. Replacement of Leu227 by Pro in thyroxine-binding globulin (TBG) is associated with complete TBG deficiency in three of eight families with this inherited defect. J. Clin. Endocrinol. Metab. 70: 804, 1990.
Janssen O.E., Refetoff S. In vitro expression of thyroxine-binding globulin (TBG) variants. Impaired secretion of TBGPRO-227 but not TBGPRO-113 J. Biol. Chem. 267: 13998, 1992.
Daiger S.P., Rummel D.P., Wang L., Cavalli-Sforza LL Detection of genetic variants with radioactive ligands. IV. X-linked, polymorphic genetic variation of thyroxine-binding globulin (TBG). Am. J. Hum. Genet. 33: 640, 1981.
Takamatsu J., Ando M., Weinberg M., Refetoff S. Isoelectric focusing variant thyroxine-binding globulin (TBG-S) in American Blacks: increased heat lability and reduced concentration in serum. J. Clin. Endocrinol. Metab. 63: 80, 1986.
Kamboh M.I., Ferrell R.E. A sensitive immunoblotting technique to identify thyroxine-binding globulin protein heterogeneity after isoelectric focusing. Biochem. Genet. 24: 273, 1986.
Kamboh M.I., Kirwood C. Genetic polymorphism of thyroxine-binding globulin (TBG) in the Pacific area. Am. J. Hum. Genet. 36: 646, 1984.
Whitehouse D.B., Hopkinson B.A., Hill A.V.S., Bowden D.K. Analysis of genetic variation in two human thyroxine-binding plasma proteins by immunodetection after isoelectric focusing. Am. J. Hum. Genet. 49: 259, 1985.
Waltz M.R., Pullman T.N., Takeda K., Sobjeszczyk P., Refetoff S. Molecular basis for the properties of the thyroxine-binding globulin-slowvariant in American Blacks. J. Endocrinol. Invest. 13: 343, 1990.
Constans J., Ribouchon M.T., Gouaillard C., Chaventré A., Clayton J. A new polymorphism of thyroxine-binding globulin in three African groups (Mali) with endemic goitre. Hum. Genet. 89: 199, 1992.
Watson F., Dick M. Distribution and inheritance of low serum thyroxine-binding globulin levels in Australian Aborigines. Med. J. Aust. 2: 385, 1980.
Dick M., Watson F. A possible variant of thyroxine-binding globulin in Australian Aborigines. Clin. Chim. Acta 116: 361, 1981.
Murata Y., Refetoff S., Same D.H., Dick M., Watson F. Variant thyroxine-binding globulin in serum of Australian Aborigines: its physical, chemical and biological properties. J. Endocrinol. Invest. 8: 225, 1985.
Refetoff S., Murata Y. X-chromosome-linked inheritance of the variant thyroxine-binding globulin in Australian Aborigines. J. Clin. Endocrinol. Metab. 60: 356, 1985.
Takeda K., Mori Y., Sobieszczyk S., Seo H., Dick M., Watson F., Flink I.L., Seino S., Bell G.I., Refetoff S. Sequence of the variant thyroxine-binding globulin of Australian Aborigines. J.Clin. Invest. 83: 1344, 1989.
Same D.H., Refetoff S., Nelson J.C., Linarelli L.G. A new inherited abnormality of thyroxine-binding globulin (TBG-San Diego) with decreased affinity for thyroxine and triiodothyronine. J. Clin. Endocrinol. Metab. 68: 114, 1989.
Bertenshaw R., Same D., Tornari J., Weinberg M., Refetoff S. Sequencing of the variant thyroxine-binding globulin (TBG)-San Diego reveals two nucleotide substitutions. Biochim. Biophys. Acta 1139: 307, 1992.
Takamatsu J., Refetoff S., Charbonneau M., Dussault J. Two new inherited defects of the thyroxine-binding globulin (TBG) molecule presenting as partial TBG deficiency. J.Clin. Invest. 79: 833, 1987.
Janssen O.E., Takeda K., Refetoff S. Sequence of the variant thyroxine-binding globulin (TBG) in a Montreal family with partial TBG deficiency. Hum. Genet. 87: 119, 1991.
Mori Y., Seino S., Takeda K., Flink I.L., Murata Y., Bell G.I., Refetoff S. A mutation causing reduced biological activity and stability of thyroxine-binding globulin probably as a result of abnormal glycosylation of the molecule. Mol. Endocrinol. 3: 575, 1989.
Kambe F., Seo H., Mori Y., Murata Y., Janssen O.E., Refetoff S., Matsui N. An additional carbohydrate chain in the variant thyroxine-binding globulin-Gary (TBGASN-96) impairs its secretion. Mol. Endocrinol. 6: 443, 1992.
Takamatsu J., Refetoff S. Inherited heat stable variant thyroxine-binding globulin (TBG-Chicago). J. Clin. Endocrinol. Metab. 63: 1140, 1986.
Bartalena L., Robbins J. Thyroid hormone-transport proteins. Clin. Lab. Med. North Am., 1993, in press.
Gershengorn M.C., Glinoer D., Fox S.H., Robbins J. Thyroxine-binding globulin synthesis by hepatocarcinoma cells in continuous culture: effect of physiological concentrations of thyroxine. Biochem. Biophys. Res. Commun. 71: 76, 1976.
Bartalena L., Brogioni S., Grasso L., Martino E. Increased serum interleukin-6 concentration in patients with subacute thyroiditis: relationship with concomitant changes in serum T4-binding globulin concentration. J. Endocrinol. Invest. 16: 213, 1993.
Geola F.L., Frumar A.M., Tataryn I.V. Biological effects of various doses of conjugated equine estrogens in postmenopausal women. J. Clin. Endocrinol. Metab. 51: 620, 1980.
Chen J.J.S., Ladenson P.W. Progesterone has no effect on serum thyroxine-binding globulin concentration in men. J. Clin. Endocrinol. Metab. 61: 983, 1985.
Ross H.A., Exalto N., Kloppenborg P.W.C., Beuraad T.J. Thyroid hormone binding in early pregnancy and the risk of spontaneous abortion. Eur. J. Obstet. Gynecol. Reprod. Biol. 32: 129, 1989.
Lao T.T., Chin R.K.H., Panesar R.S., Lam Y.M. Birth weight and thyroxine-binding globulin in preeclampsia. Gynecol. Obstet. Invest. 28: 8, 1989.
Sparre L.S. Maternal free thyroxine and thyroxine-binding globulin during pregnancy ending in congenital malformations in the offspring. Gynecol. Obstet. Invest. 27: 19, 1989.
Gardner D.F., Carithers R.L., Utiger R.D. Thyroid function tests in patients with acute and resolved hepatitis B virus infection. Ann. Intern. Med. 96: 450, 1982.
Ross D.S., Daniels G.H., Dienstag J.L., Ridgway E.C. Elevated thyroxine levels due to increased thyroxine-binding globulin in acute hepatitis. Am. J. Med. 74: 564, 1983.
Schlusser G.C., Schaffner F., Korn F. Increased serum thyroid hormone binding and decreased free hormone in chronic active hepatitis. N. Engl. J. Med. 299: 510, 1978.
Gershengorn M.C., Larsen P.R., Robbins J. Radioimmunoassay for serum thyroxine-binding globulin. Results in normal subjects and in patients with hepatocellular carcinoma. J. Clin. Endocrinol. Metab. 42: 907, 1976.
Kalk W.J., Kew M.C., Danilewitz M.D., Jacks F., Van der Walt L.A., Levin J. Thyroxine-binding globulin and thyroid function tests in patients with hepatocellular carcinoma. Hepatology 2: 72, 1982.
Terui S. Clinical evaluation of thyroxine-binding globulin (TBG) as a marker of liver tumors. Eur. J. Nucl. Med. 9: 121, 1984.
Alexopoulos A., Hutchinson W., Bari A., Keating J.J., Johnson P.J., Williams R. Hyperthyroxinaemia in hepatocellular carcinoma: relation to thyroid binding globulin in the clinical and preclinical stages of the disease. Br. J. Cancer 57: 313, 1988.
Huang M.-J., Liaw Y.-F. Thyroxine-binding globulin in patients with chronic hepatitis B virus infection: different implications in hepatitis and hepatocellular carcinoma. Am. J. Gastroenterol. 85: 281, 1990.
Geurts J., Demeester-Mirkine N., Glinoer D., Prigogine T., Femandez-Deville M., Corvilain J. Alterations in circulating thyroid hormones and thyroxine binding globulin in chronic alcoholism. Clin. Endocrinol. (Oxf.) 14: 113, 1981.
Lambert M., Zech F., De Nayer P., Jamez J., Vandercam B. Elevation of serum thyroxine-binding globulin (but not of cortisol-binding globulin and sex hormone-binding globulin) associated with the progression of human immunodeficiency virus infection. Am. J. Med. 89: 748, 1990.
Glinoer D., Naeije R., Golstein J., Fernandez-Deville M., Vanhaelst L. Alterations in circulating thyroid hormones and thyroxine-binding globulin levels during diabetic ketoacidosis. J. Endocrinol. Invest. 3: 67, 1980.
Dich J.,Gluud C.N. Effect of insulin on albumin production and incorporation of 14C-leucine into proteins in isolated parenchymal liver cells from normal rats. Acta Physiol. Scand 94: 236, 1975.
Gavin L.A., McMahon F.A, Castle J.N. Alterations in serum thyroid hormones and thyroxine-binding globulin in patients with nephrosis. J. Clin. Endocrinol. Metab. 46: 125, 1978.
Fonseca V., Thomas M., Katrak A., Sweny P., Moorhead J.F. Can urinary thyroid hormone loss cause hypothyroidism? Lancet 2: 475, 1991.
Inaba M., NishizawaY., Nishitani H., Miki T., Onishi Y., Mizutani Y., Yamakawa M., Morii H. Concentrations of thyroxine-binding globulin in sera and peritoneal dialysates in patients on chronic peritoneal ambulatory dialysis. Nephron 42: 58, 1986.
Lambert M., De Nayer P., Ghysen J., Cornette C., Beckers C., Van Ypersele De Strihou C. Decreased serum TBG concentration in the face of normal T4-binding capacity in patients on hemodialysis. Clin. Nephrol. 32: 129, 1989.
Hollander C.S., Scott R.L., Tschudy D.P., Perloth M., Waxman A., Sterling K. Increased protein-bound iodine and thyroxine-binding globulin in acute intermittent porphyria. N.Engl. J.Med. 277: 995, 1967.
Herrick A.L., McColl K.E.L., Wallace A.M., Moore M.R., Goldberg A. Elevation of hormone-binding globulins in acute intermittent porphyria. Clin. Chim. Acta 187: 141, 1990.
Ingenbleek Y., De Nayer P., De Visscher M. Thyroxine-binding globulin in infant protein-calorie malnutrition. J. Clin. Endocrinol. Metab. 30: 178, 1974.
Scriba P.C., Bauer M., Emmert D. Thyroxine binding globulin (TBG) levels in obese patients diminished by total fasting. Acta Endocrinol. (Copenh.) 85 (Suppl. 212): 85, 1977.
Moreira-Andres M.N., Black E.G., Ramsden D.B., Hoffenberg R. The effect of calorie restriction on serum thyroid hormone binding proteins and free hormone in obese patients. Clin. Endocrinol. (Oxf.) 12: 249, 1980.
Barbosa J., Doe R.P., Seal U.S. Effects of clomiphene on estrogen induced changes in plasma proteins in monkeys. J. Clin. Endocrinol. Metab. 31: 654, 1970.
Azizi F., Vagenakis A.G., Portnay G.I., Braverman L.E., Ingbar S.H. Thyroxine transport and metabolism in methadone and heroin addicts. Ann. Intern. Med. 80: 194, 1974.
Wenzel K.W. Pharmacological interference with in vitro tests of thyroid function. Metabolism 30: 717, 1981.
Federman D.D., Robbins J., Rall J.E. Effects of methyl testosterone on thyroid function, thyroxine metabolism, and thyroxine-binding protein. J.Clin. Invest. 37: 1024, 1958.
Dickinson P., Zinneman H.H., Swaim W.R., Doe R.P., Seal U.S. Effects of testosterone treatment on plasma proteins and amino acids in men. J. Clin. Endocrinol. Metab. 29: 837, 1969.
Becker U., Gluud C., Bennett P., Bennett P., and the Copenhagen Study Group for Liver Diseases The effect of oral testosterone on serum TBG levels in alcoholic cirrhotic men. Liver 8: 219, 1988.
Braverman L.E., Ingbar S.H. Effects of norethandrolone on the transport in serum and peripheral turnover of thyroxine. J. Clin. Endocrinol. Metab. 27: 389, 1967.
Gamstedt A., Jarnerot G., Kagedal B. Dose related effects of betamethasone on iodothyronines and thyroid hormone-binding proteins in serum. Acta Endocrinol. (Copenh.) 96: 484, 1981.
Refetoff S., Hagen S.R, Selenkow H.A. Estimation of the T4 binding capacity of serum TBG and TBPA by a single load-ion exchange resin method. J. Nucl. Med. 13: 2, 1972.
Roth J., Glick S.M., Cuatrecasas P., Hollander C.S. Acromegaly and other disorders of growth hormone secretion. Ann. Intern. Med. 66: 760, 1967.
Penhaligon J., Wellby M.L. Elevated serum thyroxine-binding globulin by X-chromosome transmission. Acta Endocrinol. (Copenh.) 99: 393, 1982.
Leahy B.C., Laing I., Davis D., Walton L. High serum thyroxine-binding globulin — an important cause of hyperthyroxinaemia. Postgrad. Med. J. 60: 324, 1984.
Refetoff S., Selenkow H.A. Familial thyroxine-binding globulin deficiency in a patient with Turner’s syndrome (X0): genetic study of a kindred. N.Engl. J. Med. 278: 1081, 1968.
Gerstner J.B., Kaplan R.H. Hyperthyroidism with normal concentration of total serum thyroxine and triiodothyronine. J. Clin. Endocrinol. Metab. 42: 64, 1976.
Horwitz D.L., Refetoff S. Graves’ disease associated with familial deficiency of thyroxine-binding globulin. J. Clin. Endocrinol. Metab. 44: 242, 1977.
Yabu U., Amino N., Nakatari K., Inchihara K., Azukizawa M., Miyai K. Graves’ disease associated with elevated thyroxine-binding globulin concentration. J. Clin. Endocrinol. Metab. 51: 325, 1980.
Nikolai T.F., Seal U.S. X-chromosome linked familial decrease in serum thyroxine-binding globulin. J. Clin. Endocrinol. Metab. 25: 835, 1966.
Moloshok R.E., Hsu L.Y.F., Seal U.S., Hirschhorn K. Partial thyroxine-binding globulin deficiency in a family. Pediatrics 44: 518, 1969.
Robbins J. Inherited variations in thyroxine transport. Mt. Sinai J. Med. 49: 511, 1973.
Sakurada T., Yamaguchi T., Yoshida K., Yamamoto M., Onodera S., Saito S. Kinetics of thyroxine and triiodothyronine in a case of thyroxine-binding globulin deficiency with hypothyroidism. Tohoku J. Exp. Med. 112: 133, 1974.
Hansen E., Kirkegaard C., Friis T., Siersbaek-Nielsen K. Normal response to thyrotrophin-releasing hormone (TRH) in familial thyroxine-binding globulin deficiency. Acta Endocrinol. (Copenh.) 80: 297, 1975.
Konno N. Serum thyrotropin response to thyrotropin-releasing hormone and free thyroid hormone indices in patients with familial thyroxine-binding globulin deficiency. Endocrinol. Jpn. 23: 313, 1976.
Same D.H., Refetoff S. Normal cellular uptake of thyroxine from serum of patients with familial dysalbuminemic hyperthyroxinemia or elevated thyroxine-binding globulin. J. Clin. Endocrinoir Metab. 67: 1166, 1988.
Bartalena L., Mariotti S., Pinchera A. Radioimmunoassay of thyroid hormones. In: Patrono C., Peskar B.A. (eds.), Handbook of Experimental Pharmacology, vol. 82. Springer-Verlag, Berlin, 1987, p. 401.
Ekins R. Measurement of free hormones in blood. Endocr. Rev. 11: 5, 1990.
Pardridge W.M. Plasma protein-mediated transport of steroid and thyroid hormones. Am. J. Physiol. 252: E157, 1987.
Mendel C.M. The free hormone hypothesis: a physiologically based mathematical model. Endocr. Rev. 10: 232, 1989.
Mendel C.M., Cavalieri R.R. Transport of thyroid hormones in health and disease: recent controversies surrounding the free hormone hypothesis. Thyroid Today 11: 1, 1988.
Same D., Barokas K., Scherberg N.H., Refetoff S. Elevated serum thyreoglobulin level in congenital thyroxine-binding globulin (TBG) deficiency. J. Clin. Endocrinol. Metab. 57: 665, 1983.
Mendel C.M., Cavalieri R.R., Weisiger R.A. Uptake of thyroxine by the perfused rat liver: implications for the free hormone hypothesis. Endocrinology 123: 1817, 1988.
Robbins J., Johnson M.L. Possible significance of multiple transport proteins for the thyroid hormones. In: Albertini A., Ekins R.P. (eds.), Free Hormones in Blood. Elsevier, Amsterdam, 1982, p. 53.
Hashizume K., Sakurai A., Miyamoto T., Yamauchi K., Nishii Y. Effect of thyroxine-binding globulin (TBG) on thyroxine (T4) uptake by human peripheral mononuclear cells: evidence of TBG-dependent uptake of T4. Endocrinol. Jpn. 33: 665, 1986.
Divino C.M., Schlusser G.C. Transthyretin receptors on human astrocytoma cells. J. Clin. Endocrinol. Metab. 71: 1265, 1989.
Divino C.M., Schlusser G.C. Receptor-mediated uptake and internalization of transthyretin. J. Biol. Chem. 265: 1425, 1990.
Benvenga S., Robbins J. Enhancement of thyroxine entry into low density lipoprotein (LDL) receptor-competent fibroblasts by LDL: an additional mode of entry of thyroxine into cells. Endocrinology 126: 993, 1990.
Pontecorvi A., Robbins J. The plasma membrane and thyroid hormone entry into cells. Trends Endocrinol. Metab. 1: 90, 1989.
Schreiber G., Aldred A.R., Jaworowski A. Thyroxine transport from blood to brain via transthyretin synthesis in choroid plexus, Am. J. Physiol. 258: R338, 1990.
Author information
Authors and Affiliations
Additional information
Presented as the Lecture of the Harington-De Visscher Prize of the European Thyroid Association at the 20th Annual Meeting, Dublin, June 20–25, 1992.
Rights and permissions
About this article
Cite this article
Bartalena, L. Studies on thyroxine-binding globulin. J Endocrinol Invest 16, 353–371 (1993). https://doi.org/10.1007/BF03348858
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348858